RetinalGenix Technologies (RTGN) Change in Accured Expenses (2021 - 2026)
RetinalGenix Technologies (RTGN) reported Change in Accured Expenses of $960.0 for Q1 2026, little changed on a YoY basis from $960.0 in Q1 2025, and little changed sequentially from $960.0 in Q4 2025.
RetinalGenix Technologies (RTGN) Change in Accured Expenses (2021 - 2026) Analysis & Trends
RetinalGenix Technologies (RTGN) has 6 years of Change in Accured Expenses data on file, last reported at $960.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses changed 0.0% year-over-year to $960.0; the trailing twelve-month figure through Mar 2026 stood at $3840.0 (up 105.2% YoY), and the FY2025 full-year result was $3840.0, changed 0.0% from the prior year.
- Change in Accured Expenses steadied at $960.0 in Q1 2026, from $960.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $112485.0 in Q3 2022 to a low of -$110265.0 in Q4 2022.
- A 5-year average of $1036.5 and a median of $960.0 in 2023 frame the typical range for Change in Accured Expenses.
- Across the five-year window, Change in Accured Expenses jumped 8086.25% in 2024 and tumbled 9654.38% in 2025, its largest moves.
- Tracing RTGN's Change in Accured Expenses over 5 years: stood at -$110265.0 in 2022, then jumped by 100.87% to $960.0 in 2023, then changed by 0.0% to $960.0 in 2024, then changed by 0.0% to $960.0 in 2025, then changed by 0.0% to $960.0 in 2026.
- Business Quant data shows RTGN's Change in Accured Expenses at $960.0 in Q1 2026, $960.0 in Q4 2025, and -$91722.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.21 Bn | 176.92 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 47.39 Bn | 43.72 Bn | 1.29 Bn | -347.10 Mn |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.16 Bn | 1.98 Bn | -250.00 Mn |
| 7 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 145.10 Mn |
| 8 | Smith & Nephew | 27.03 Bn | 26.46 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.43 Bn | 2.07 Bn | 21.07 Mn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | 960.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 960.00 |
| Mar 31, 2026 | 960.00 |
| Dec 31, 2025 | 960.00 |
| Dec 31, 2025 | 960.00 |
| Sep 30, 2025 | -91,722.00 |
| Sep 30, 2025 | -91,722.00 |
| Jun 30, 2025 | 93,642.00 |
| Jun 30, 2025 | 93,642.00 |
| Mar 31, 2025 | 960.00 |
| Mar 31, 2025 | 960.00 |
| Dec 31, 2024 | 960.00 |
| Dec 31, 2024 | 960.00 |
| Sep 30, 2024 | 960.00 |
| Sep 30, 2024 | 960.00 |
| Jun 30, 2024 | -76,668.00 |
| Jun 30, 2024 | -76,668.00 |
| Mar 31, 2024 | 78,588.00 |
| Mar 31, 2024 | 78,588.00 |
| Dec 31, 2023 | 960.00 |
| Dec 31, 2023 | 960.00 |